Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jianliang Deng"'
Autor:
Xuantao Hu, Zhengxiao Ouyang, Guangyao Jiang, Minghui Chen, Tao Li, Jianliang Deng, Daishui Yang
Publikováno v:
Biochemical and Biophysical Research Communications. 542:1-8
Osteoporosis is a common skeletal disorder characterized by low bone mass, defective bone microstructure, and increased risk of fracture. It’s well known that excessive activation of osteoclasts plays a vital role in the pathogenesis of osteoporosi
Autor:
Yunlei Zhang, Liangliang Xiang, Yan Zhou, Tengyang Ni, Yanqing Liu, Ishikawa Shintaro, Haibo Wang, Weimin Wang, Feng Jin, Jianliang Deng
Publikováno v:
Oncology Reports
Protein/nucleic acid deglycase DJ‑1 (DJ‑1) is a 20‑kDa conserved protein, which belongs to the DJ‑1/ThiJ/Pfp Ⅰ protein superfamily. Immunohistochemistry was performed to investigate the expression of DJ‑1 in a colorectal cancer (CRC) tiss
Autor:
Li Tao, Yan Zhou, Liangliang Xiang, Yanqing Liu, Sunagawa Masatara, Tengyang Ni, Weimin Wang, Mengying Lv, Jianliang Deng, Zhen Zhou
Publikováno v:
Biomarkers in Medicine. 14:421-432
Aim: Gastric cancer (GC) is one of the most common malignant tumors in the world. It is important to find accurate and reliable biomarkers in order to decrease whole morbidity and mortality. Results: We examined the expression of COX-2 and mTOR on GC
Autor:
Sunagawa Masatara, Mengying Lv, Dan Li, Jianliang Deng, Tengyang Ni, Liangliang Xiang, Li Tao, Yan Zhou, Yanqing Liu, Xiancheng Gu, Weimin Wang
Publikováno v:
Cell Adhesion & Migration, Vol 13, Iss 1, Pp 272-283 (2019)
Cell Adhesion & Migration
Cell Adhesion & Migration
Colorectal cancer has a common cause of morbidity and mortality. Therefore, it is urgent to detect reliable biomarkers to predict prognosis in CRC. Here, we determined the expression of TIMP-2 and MMP-9 in a CRC tissue microarray by immunohistochemis
Autor:
Zhen Zhou, Weimin Wang, Jianliang Deng, Tengyang Ni, Zewen Chu, Mengying Lv, Yanqing Liu, Yan Zhou
Publikováno v:
Bulletin du cancer. 109(3)
Colorectal cancer (CRC) is one of the most common malignant tumors in the world. Despite great advances in medical technology, the survival rate of CRC patients is still extremely low, mainly due to recurrence and chemotherapy resistance. Therefore,
Autor:
Zhijun Ge, Wei-min Wang, Jianwei Zhou, Yongfei Tan, Qiang Yao, Qianqian Wang, Yan Zhou, Wenjiao Chen, Jianliang Deng
Publikováno v:
Oncology Reports. 38:245-252
Colorectal cancer (CRC) is one of the most common malignant tumors, and its high rates of recurrence and metastasis are the important causes of treatment failure in CRC. Therefore, the development of valuable molecular markers to accurately predict t